AMP-224
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
PD-1
Description:
A fusion protein that contains the extracellular domain of PD-1 ligand 2 (B7-DC; PDCDILG2) and the Fc region of human immunoglobulin (Ig) G1. AMP-224 does not bind normal activated T-cells, but binds to PD-1 on chronically stimulated T-cells and reduces their proliferation.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
A fusion protein that contains the extracellular domain of PD-1 ligand 2 (B7-DC; PDCDILG2) and the Fc region of human immunoglobulin (Ig) G1. AMP-224 does not bind normal activated T-cells, but binds to PD-1 on chronically stimulated T-cells and reduces their proliferation.
Synonyms:
2661380; AMP-244; GSK-2661380
MSDS:
Inquire
Quality Standard:
In-house
Quantity:
Milli-Grams
Current Developer:
MedImmune; National Cancer Institute (USA)
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PD-1 Products


Pidilizumab
(CAS: 1036730-42-3)

A humanized, immunoglobulin (Ig) G1 monoclonal antibody directed against human inhibitory receptor programmed cell death 1 (PD-1; PDCD1), with potential immune ...

nivolumab
(CAS: 946414-94-4)

Nivolumab, marketed as Opdivo, is a humanized IgG4 anti-PD-1 monoclonal antibody used to treat cancer. Nivolumab works as a checkpoint inhibitor, blocking a sig...

AMP-224

A fusion protein that contains the extracellular domain of PD-1 ligand 2 (B7-DC; PDCDILG2) and the Fc region of human immunoglobulin (Ig) G1. AMP-224 does not ...

pembrolizumab
(CAS: 1374853-91-4)

Pembrolizumab (formerly MK-3475 and lambrolizumab, trade name Keytruda) is a humanized antibody used in cancer immunotherapy. It targets the programmed cell dea...

MEDI0680

A humanized immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1)...

Quick Inquiry

Verification code

Featured Items